Cargando…
Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201
SIMPLE SUMMARY: Glycosylation is an important post-translational modification made on mammalian proteins and lipids. In cancer cells, the disruption of several glycosylation patterns, such as the O-glycosylation, has been observed. The expression of incomplete/truncated O-glycans in cancer cells occ...
Autores principales: | Tsang, Kwong Y., Fantini, Massimo, Zaki, Anjum, Mavroukakis, Sharon A., Morelli, Maria Pia, Annunziata, Christina M., Arlen, Philip M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599200/ https://www.ncbi.nlm.nih.gov/pubmed/36291783 http://dx.doi.org/10.3390/cancers14204999 |
Ejemplares similares
-
Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas
por: Fantini, Massimo, et al.
Publicado: (2018) -
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
por: Cole, Christopher B., et al.
Publicado: (2023) -
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
por: Cole, Christopher B., et al.
Publicado: (2023) -
Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas
por: Tsang, Kwong yok, et al.
Publicado: (2022) -
Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
por: Zeligs, Kristen P., et al.
Publicado: (2020)